Cosmos Health CEO acquires shares via debt exchange

Siokas Grigorios reported open-market purchase transactions in this Form 4 filing.

Rhea-AI Filing Summary

Siokas Grigorios reported open-market purchase transactions in this Form 4 filing.

Cosmos Health Inc. director and CEO Grigorios Siokas acquired additional common shares through a debt-for-equity exchange with the company. Under a Debt Exchange Agreement dated June 11, 2026, he received 218,447 shares of common stock at an Exchange Rate of $0.206 per share, equal to the fair market value on that date, in exchange for $45,000 of debt the company owed him. Following this transaction, he holds 13,481,808 common shares directly. This increases his equity stake while reducing a related-party debt obligation on the company’s balance sheet.

Insider Trade Summary

Net Buyer: 218,447 shares

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 218,447 shs ($45K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	218,447	$0.206	$45K

Holdings After Transaction: Common Stock, par value $.001 — 13,481,808 shares (Direct)

Footnotes (1)

1. F1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of June 11, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.206 per share, the fair market value of the Common Stock on June 11, 2026, in exchange for a total amount of $45,000 in debt the Company owed to Mr. Siokas.

Key Figures

Shares acquired: 218,447 shares Exchange rate: $0.206 per share Debt cancelled: $45,000 +1 more

4 metrics

Shares acquired 218,447 shares Common stock received by CEO in debt exchange

Exchange rate $0.206 per share Fair market value on June 11, 2026 under Debt Exchange Agreement

Debt cancelled $45,000 Company debt to CEO exchanged for shares

Shares owned after 13,481,808 shares CEO’s direct common stock holdings following the transaction

Key Terms

Debt Exchange Agreement, Exchange Shares, Exchange Rate, fair market value

4 terms

Debt Exchange Agreement financial

"Pursuant to a debt exchange agreement by and between Grigorios Siokas..."

Exchange Shares financial

"these shares are Exchange Shares (as defined in the Debt Exchange Agreement)..."

Exchange Rate financial

"being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement)..."

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

fair market value financial

"the fair market value of the Common Stock on June 11, 2026..."

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cosmos Health (COSM) CEO Grigorios Siokas report in this Form 4?

Cosmos Health CEO Grigorios Siokas reported acquiring additional common shares. He received stock in exchange for cancelling company debt owed to him, increasing his direct equity stake while reducing that specific debt obligation on the company’s books.

How many Cosmos Health (COSM) shares did the CEO acquire and at what price?

Grigorios Siokas acquired 218,447 Cosmos Health common shares at an exchange rate of $0.206 per share. This rate matched the fair market value of the stock on June 11, 2026, as referenced in the related Debt Exchange Agreement.

What is the size of the debt exchanged in the Cosmos Health (COSM) insider transaction?

The transaction exchanged $45,000 of debt owed by Cosmos Health to CEO Grigorios Siokas for common shares. This converted a related-party liability into equity, aligning the CEO further with shareholders through additional stock ownership instead of a debt claim.

How many Cosmos Health (COSM) shares does the CEO own after this transaction?

After the reported transaction, CEO Grigorios Siokas directly owns 13,481,808 Cosmos Health common shares. This figure reflects his position immediately following the debt-for-equity exchange described in the Form 4 and shows his substantial ongoing ownership stake.

Was the Cosmos Health (COSM) CEO purchase an open-market buy or a debt exchange?

Although coded as a purchase, the footnote explains it is a debt exchange. The CEO received shares as “Exchange Shares” at $0.206 per share in return for cancelling $45,000 of company debt, rather than paying cash in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 01:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last) (First) (Middle)

5 AG. GEORGIOU STR.

(Street)

PILEA THESSALONIKI TK57001

(City) (State) (Zip)

GREECE

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $.001	06/11/2026	06/11/2026	P(1)		218,447	A	$0.206	13,481,808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of June 11, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.206 per share, the fair market value of the Common Stock on June 11, 2026, in exchange for a total amount of $45,000 in debt the Company owed to Mr. Siokas.

	/s/ Grigorios Siokas	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)